
Nephrologist

No OPD information available
Fabry Disease
Alport Syndrome
Chronic Kidney Disease
Familial Cold Autoinflammatory Syndrome
Farber Lipogranulomatosis
Gaucher Disease
Glomerulonephritis
Kidney Transplant
Lupus Nephritis
Membranoproliferative Glomerulonephritis
Muckle-Wells Syndrome
Neonatal Onset Multisystem Inflammatory Disease
Polycystic Kidney Disease
Systemic Lupus Erythematosus (SLE)
Kathy M. Nicholls is a female healthcare provider who helps people with different health conditions like Fabry Disease, Alport Syndrome, Chronic Kidney Disease, and more. She also supports patients who need kidney transplants and those with autoimmune disorders like Lupus Nephritis and Systemic Lupus Erythematosus (SLE).
Kathy M. Nicholls uses her special skills and knowledge to diagnose and treat various kidney and genetic disorders. She is known for her expertise in managing complex conditions and providing personalized care to each patient.
Patients trust Kathy M. Nicholls because she communicates with them in a caring and understanding way. She listens to their concerns, explains medical information clearly, and involves them in decisions about their health. Patients feel supported and valued under her care.
To stay updated with the latest medical knowledge and research, Kathy M. Nicholls regularly attends conferences, reads scientific journals, and collaborates with other healthcare professionals. This helps her provide the best and most effective treatments to her patients.
Kathy M. Nicholls works closely with her colleagues and other medical professionals to ensure that patients receive comprehensive and coordinated care. She values teamwork and believes in the importance of a multidisciplinary approach to healthcare.
Through her work, Kathy M. Nicholls has positively impacted many patients' lives by improving their health outcomes and quality of life. Her dedication to patient care and commitment to excellence have earned her recognition in the medical community.
One of Kathy M. Nicholls's notable publications is "Enhancing diagnostic outcomes in kidney genetic disorders: the KidGen national kidney genomics study protocol," which highlights her contribution to advancing medical knowledge in the field of nephrology.
Additionally, she is involved in a clinical trial focused on evaluating a new treatment for patients with Primary IgA Nephropathy, demonstrating her commitment to research and innovation in patient care.
Enrollment Status: Active not recruiting
Published: January 27, 2025
Intervention Type: Drug
Study Drug: Mezagitamab
Study Phase: Phase 1
